Guardant Health, Inc. (GH)
Largest Insider Buys in Sector
GH Stock Price History Chart
GH Stock Performance
About Guardant Health, Inc.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.
Insider Activity of Guardant Health, Inc.
Over the last 12 months, insiders at Guardant Health, Inc. have bought $38,963 and sold $233,035 worth of Guardant Health, Inc. stock.
On average, over the past 5 years, insiders at Guardant Health, Inc. have bought $8.18M and sold $640.56M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Kalia Kumud (Chief Information Officer) — $38,963.
The last purchase of 2,187 shares for transaction amount of $38,963 was made by Kalia Kumud (Chief Information Officer) on 2024‑03‑18.
List of Insider Buy and Sell Transactions, Guardant Health, Inc.
| 2024-06-04 | Sale | Joyce Meghan V. | director | 100 <0.0001% | $27.87 | $2,787 | +7.26% | |
| 2024-03-18 | Kalia Kumud | Chief Information Officer | 2,187 0.0018% | $17.82 | $38,963 | +12.89% | ||
| 2024-03-04 | Sale | Joyce Meghan V. | director | 100 <0.0001% | $19.05 | $1,905 | +1.00% | |
| 2023-12-04 | Sale | Joyce Meghan V. | director | 100 <0.0001% | $26.34 | $2,634 | -16.48% | |
| 2023-12-01 | Sale | Kalia Kumud | Chief Information Officer | 5,800 0.0049% | $26.37 | $152,954 | -13.69% | |
| 2023-09-12 | Sale | Kalia Kumud | Chief Information Officer | 2,125 0.0018% | $32.59 | $69,254 | -24.85% | |
| 2023-09-05 | Sale | Joyce Meghan V. | director | 100 <0.0001% | $35.01 | $3,501 | -29.82% | |
| 2023-06-15 | Sale | Joyce Meghan V. | director | 2,766 0.0027% | $37.55 | $103,863 | -31.14% | |
| 2023-06-09 | Kalia Kumud | Chief Information Officer | 2,981 0.0029% | $32.71 | $97,498 | -20.79% | ||
| 2023-03-15 | Eltoukhy Helmy | Co-Chief Executive Officer | 8,600 0.0082% | $26.15 | $224,928 | -0.41% | ||
| 2023-03-14 | Eltoukhy Helmy | Co-Chief Executive Officer | 84,452 0.0813% | $26.33 | $2.22M | 0.00% | ||
| 2023-03-14 | Talasaz AmirAli | Co-Chief Executive Officer | 12,750 0.0123% | $26.40 | $336,564 | 0.00% | ||
| 2023-03-13 | Talasaz AmirAli | Co-Chief Executive Officer | 60,000 0.0581% | $25.66 | $1.54M | +3.21% | ||
| 2023-03-03 | Sale | Kalia Kumud | Chief Information Officer | 6,500 0.0063% | $31.92 | $207,466 | -16.18% | |
| 2022-11-15 | Sale | Kalia Kumud | Chief Information Officer | 3,125 0.0031% | $51.87 | $162,082 | -41.89% | |
| 2022-08-17 | Sale | Kalia Kumud | Chief Information Officer | 2,000 0.002% | $51.39 | $102,781 | -30.89% | |
| 2022-08-11 | Sale | Merrill Amelia | SVP, People | 4,500 0.0045% | $54.32 | $244,441 | -32.94% | |
| 2022-03-10 | Sale | MERESMAN STANLEY J | 4,934 0.0048% | $58.74 | $289,823 | -18.12% | ||
| 2022-02-10 | Sale | MERESMAN STANLEY J | director | 4,934 0.0049% | $73.80 | $364,129 | -33.55% | |
| 2022-01-10 | Sale | MERESMAN STANLEY J | director | 4,934 0.0045% | $86.08 | $424,719 | -45.47% |
Insider Historical Profitability
| Kalia Kumud | Chief Information Officer | 12722 0.0049% | $29.39 | 2 | 5 | <0.0001% |
| Joyce Meghan V. | director | 4621 0.0036% | $29.39 | 0 | 5 | |
| SOFTBANK VISION FUND (AIV M1) L.P. | 10 percent owner | 27850460 22.9449% | $29.39 | 1 | 0 | +5.91% |
| SVF Bluebird (Cayman) Ltd | 10 percent owner | 7037960 5.7983% | $29.39 | 0 | 4 | |
| Eltoukhy Helmy | Co-Chief Executive Officer | 2049238 1.6883% | $29.39 | 4 | 37 | <0.0001% |
| Talasaz AmirAli | Co-Chief Executive Officer | 1902345 1.5673% | $29.39 | 4 | 48 | <0.0001% |
| Wiley Michael J | Chief Legal Officer | 111171 0.0916% | $29.39 | 0 | 13 | |
| Lanman Richard B. | Chief Medical Officer | 82015 0.0676% | $29.39 | 0 | 7 | |
| Merrill Amelia | SVP, People | 20208 0.0166% | $29.39 | 0 | 1 | |
| Kaul Samir | director | 14943 0.0123% | $29.39 | 0 | 7 | |
| BERTOCCI DEREK A | Chief Financial Officer | 6373 0.0053% | $29.39 | 0 | 11 | |
| MERESMAN STANLEY J | 4059 0.0033% | $29.39 | 0 | 36 | ||
| Nishar Dipchand | director | 2321 0.0019% | $29.39 | 0 | 1 | |
| CLARK IAN T | director | 0 0% | $29.39 | 0 | 39 |
Institutional Investor Ownership
| The Vanguard Group | $235.93M | 9.35 | 11.44M | +2.74% | +$6.3M | <0.01 | |
| BlackRock | $227.22M | 9 | 11.01M | +1.68% | +$3.76M | 0.01 | |
| Baillie Gifford Co | $128.57M | 5.09 | 6.23M | +0.86% | +$1.1M | 0.1 | |
| Deep Track Capital Lp | $123.78M | 4.9 | 6M | +20% | +$20.63M | 0.57 | |
| Cadian Capital Management LP | $119.51M | 4.73 | 5.79M | +715.88% | +$104.86M | 4.25 | |
| Eventide Asset Management | $86.22M | 3.42 | 4.18M | +7.49% | +$6.01M | 1.36 | |
| Temasek Holdings | $84.81M | 3.36 | 4.11M | +11.92% | +$9.03M | 0.47 | |
| Capital International Investors | $78.87M | 3.12 | 3.82M | -4.47% | -$3.69M | 0.02 | |
| Fidelity Investments | $62.44M | 2.47 | 3.03M | -42.37% | -$45.9M | <0.01 | |
| Parkwood LLC | $1.9M | 2.29 | 2.8M | 0% | +$0 | 0.2 | |
| Citadel Advisors LLC | $57.57M | 2.28 | 2.79M | +9,912.69% | +$56.99M | 0.04 | |
| Geode Capital Management | $54.51M | 2.16 | 2.64M | +5.1% | +$2.64M | 0.01 | |
| State Street | $54.22M | 2.15 | 2.63M | +2.17% | +$1.15M | <0.01 | |
| Braidwell Lp | $51.1M | 2.02 | 2.48M | +226.36% | +$35.44M | 2.88 | |
| Fil Ltd | $39.61M | 1.57 | 1.92M | -2.59% | -$1.05M | 0.04 | |
| Credit Suisse | $38.06M | 1.51 | 1.84M | +5.04% | +$1.82M | 0.04 | |
| T. Rowe Price | $31.88M | 1.26 | 1.55M | -15.08% | -$5.66M | <0.01 | |
| Point72 Asset Management | $29.43M | 1.17 | 1.43M | New | +$29.43M | 0.06 | |
| Invesco | $27.53M | 1.09 | 1.33M | +22.45% | +$5.05M | 0.01 | |
| Charles Schwab | $26.35M | 1.04 | 1.28M | +3.65% | +$927,978.65 | 0.01 | |
| Goldman Sachs | $24.77M | 0.98 | 1.2M | +31.99% | +$6M | 0.01 | |
| Millennium Management LLC | $24.55M | 0.97 | 1.19M | +65.27% | +$9.7M | 0.02 | |
| Voloridge Investment Management, LLC | $23.95M | 0.95 | 1.16M | +29.91% | +$5.51M | 0.05 | |
| Morgan Stanley | $22.73M | 0.9 | 1.1M | -55.19% | -$27.99M | <0.01 | |
| Franklin Templeton Investments | $22.02M | 0.87 | 1.07M | -22.04% | -$6.23M | 0.01 | |
| Northern Trust | $21.6M | 0.86 | 1.05M | -3.01% | -$669,587.96 | <0.01 | |
| Deutsche Bank | $20.94M | 0.83 | 1.02M | -12.49% | -$2.99M | 0.01 | |
| BNY Mellon | $20.03M | 0.79 | 971,064 | -12.03% | -$2.74M | <0.01 | |
| Man Group Plc | $20.04M | 0.79 | 971,353 | -3.64% | -$756,976.57 | 0.05 | |
| Federated Hermes | $18.71M | 0.74 | 906,900 | -0.03% | -$6,189.00 | 0.04 | |
| Ubs Asset Management Americas Inc | $18.61M | 0.74 | 902,033 | +41.81% | +$5.49M | 0.01 | |
| Barclays | $18.46M | 0.73 | 894,840 | +107.74% | +$9.57M | 0.01 | |
| Nuveen | $16.87M | 0.67 | 817,509 | -12.99% | -$2.52M | 0.01 | |
| Aristotle Atlantic Partners LLC | $16.65M | 0.66 | 806,895 | -3.59% | -$619,931.51 | 0.54 | |
| Two Sigma Advisers LP | $16.38M | 0.65 | 793,900 | -1.66% | -$276,442.00 | 0.03 | |
| Deerfield Management | $16.33M | 0.65 | 791,735 | 0% | +$0 | 0.32 | |
| Eagle Health Investments Lp | $15.06M | 0.6 | 730,209 | +507.95% | +$12.59M | 2.87 | |
| Squarepoint Ops LLC | $14.76M | 0.59 | 715,312 | +91.75% | +$7.06M | 0.06 | |
| Blue Water Life Science Advisors Llc | $11.78M | 0.47 | 571,047 | 0% | +$0 | 11.08 | |
| The Manufacturers Life Insurance Company | $10.99M | 0.44 | 532,502 | +0.53% | +$57,475.18 | 0.01 | |
| Bank of America | $10.93M | 0.43 | 529,604 | -12.68% | -$1.59M | <0.01 | |
| JENNISON ASSOCIATES LLC | $10.1M | 0.4 | 489,657 | +2.04% | +$202,400.93 | 0.01 | |
| Prosight Management Lp | $9.7M | 0.38 | 470,000 | New | +$9.7M | 2.7 | |
| Candriam S C A | $9.62M | 0.38 | 466,137 | 0% | +$0 | 0.06 | |
| Standard Life | $9.44M | 0.37 | 457,791 | +32.28% | +$2.3M | 0.02 | |
| Eversept Partners LP | $9.27M | 0.37 | 449,586 | New | +$9.27M | 0.7 | |
| Mitsubishi UFJ Trust and Banking Corporation | $8.3M | 0.33 | 402,310 | New | +$8.3M | 0.02 | |
| ARK Investment Management LLC | $7.45M | 0.3 | 361,166 | -17.56% | -$1.59M | 0.05 | |
| Sumitomo Mitsui Trust Holdings | $6.55M | 0.26 | 317,694 | -7.58% | -$537,432.11 | <0.01 | |
| Adage Capital Partners Gp L L C | $6.54M | 0.26 | 316,800 | New | +$6.54M | 0.01 |